Graham P Lidgard
Overview
Explore the profile of Graham P Lidgard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Anderson B, Suh Y, Choi B, Lee H, Yab T, Taylor W, et al.
Clin Cancer Res
. 2018 May;
24(22):5724-5734.
PMID: 29844130
Gastric adenocarcinoma is the third most common cause of cancer mortality worldwide. Accurate and affordable noninvasive detection methods have potential value for screening and surveillance. Herein, we identify novel methylated...
12.
Kisiel J, Klepp P, Allawi H, Taylor W, Giakoumopoulos M, Sander T, et al.
Clin Gastroenterol Hepatol
. 2018 May;
17(5):914-921.e5.
PMID: 29775793
Background & Aims: Patients with inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn's disease, are at increased risk for colorectal cancer (CRC). Analyses of DNA methylation patterns in stool...
13.
Levin T, Corley D, Jensen C, Marks A, Zhao W, Zebrowski A, et al.
Dig Dis Sci
. 2017 Jan;
62(3):678-688.
PMID: 28044229
Background: Fecal immunochemical test (FIT) screening detects most asymptomatic colorectal cancers. Combining FIT screening with stool-based genetic biomarkers increases sensitivity for cancer, but whether DNA biomarkers (biomarkers) differ for cancers...
14.
15.
Imperiale T, Ransohoff D, Itzkowitz S, Levin T, Lavin P, Lidgard G, et al.
N Engl J Med
. 2014 Mar;
370(14):1287-97.
PMID: 24645800
Background: An accurate, noninvasive test could improve the effectiveness of colorectal-cancer screening. Methods: We compared a noninvasive, multitarget stool DNA test with a fecal immunochemical test (FIT) in persons at...
16.
Heigh R, Yab T, Taylor W, Hussain F, Smyrk T, Mahoney D, et al.
PLoS One
. 2014 Jan;
9(1):e85659.
PMID: 24465639
Objectives: Precursors to 1/3 of colorectal cancer (CRC), serrated polyps have been under-detected by screening due to their inconspicuous, non-hemorrhagic, and proximal nature. A new multi-target stool DNA test (multi-target...
17.
Lidgard G, Domanico M, Bruinsma J, Light J, Gagrat Z, Oldham-Haltom R, et al.
Clin Gastroenterol Hepatol
. 2013 May;
11(10):1313-8.
PMID: 23639600
Background & Aims: Colorectal cancer (CRC) and advanced precancers can be detected noninvasively by analyses of exfoliated DNA markers and hemoglobin in stool. Practical and cost-effective application of a stool...
18.
Ahlquist D, Zou H, Domanico M, Mahoney D, Yab T, Taylor W, et al.
Gastroenterology
. 2011 Nov;
142(2):248-56.
PMID: 22062357
Background & Aims: Technical advances have led to stool DNA (sDNA) tests that might accurately detect neoplasms on both sides of the colorectum. We assessed colorectal neoplasm detection by a...
19.
Ahlquist D, Taylor W, Mahoney D, Zou H, Domanico M, Thibodeau S, et al.
Clin Gastroenterol Hepatol
. 2011 Oct;
10(3):272-7.e1.
PMID: 22019796
Background & Aims: Several noninvasive tests have been developed for colorectal cancer (CRC) screening. We compared the sensitivities of a multimarker test for stool DNA (sDNA) and a plasma test...